27^th European Diabetes Congress June 20-21, 2018 | Rome, Italy

Diabetes Research in Clinical Practice

Novel remedial targets accessible for diabetes incorporates Incretion based treatments, oral helpful operators like secretagogues, beta cell recovery and expansion and foundational microorganism treatments. Embryonic undeveloped cell and fetal antecedent cell transplantation treatments are the significant undifferentiated cell treatments accessible for Diabetes. Aside from the above, different computational methodologies in Diabetes administration control have been presented as of late which are assuming an imperative part in recognizable proof of qualities bringing about diabetes helping in Early Detection of Diabetes. These procedures are likewise valuable in concentrating on the compound etiologist of Diabetes revealing different treatment prospects and model development forms for survival expectation. Follow Diabetes Conferences and Endocrinology Coneferences for more details.

• Non-invasive diagnostic tool for detecting cardiovascular disease in diabetes
• Diabetes and cancer
• Oral therapies: secretagogues
• Incretin based therapies
• Novel agents in treatment
• Updates of anti-diabetic agents
• Measurement of insulin resistance and secretion in diabetes clinic
• Diabetes Case Reports
• Polydipsia

Recommended Sessions

Related Journals

Are you interested in